UPSTREAM BIO, INC. financials

UPB CIK 0002022626

Source: EDGAR filings · Built 2026-06-02T04:16:59Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -133.44M -59.68M -38.07M
EBITDA -160.17M -77.67M -40.05M
Working Capital 338.35M 468.42M 110.48M
Net Debt -100.11M -323.86M -25.79M
Operating Margin -5618.82% -3281.18% -1685.46%
Net Margin -5026.03% -2650.04% -862.90%
Return on Equity (ROE) -42.22% -13.37% 16.68%
Return on Assets (ROA) -40.55% -13.04% -17.52%
Current Ratio 26.15× 44.63× 17.96×
Debt-to-Equity 0.00× 0.00× -0.00×
Cash Conversion Ratio 0.93× 0.94× 1.85×
Accruals Ratio -0.03× -0.01× 0.15×
SBC % of Revenue 362.02% 253.33% 139.71%
CapEx Coverage -807.73× -115.80× -263.38×
Free Cash Flow Per Share $-2.48 $-4.36 $-12.89

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/S 515.96× 371.83×
P/B 4.33× 1.88×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 2.85M 2.37M 2.38M
Research and Development Expense 136.81M 62.97M 31.80M
Operating Expenses 163.22M 80.13M 42.49M
Operating Income (Loss) -160.36M -77.76M -40.11M
Income Tax Expense (Benefit) 0 0 0
Net Income (Loss) Attributable to Parent -143.44M -62.81M -20.54M
Earnings Per Share, Basic $-2.66 $-5.58 $-12.95
Weighted Average Number of Shares Outstanding, Basic 53.85M 13.68M 2.95M
Earnings Per Share, Diluted $-2.66 $-5.58 $-12.95
Weighted Average Number of Shares Outstanding, Diluted 53.85M 13.68M 2.95M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 101.58M 325.89M 25.83M
Assets, Current 351.80M 479.16M 117.00M
Assets 353.77M 481.72M 117.20M
Liabilities, Current 13.45M 10.74M 6.51M
Liabilities 14.00M 11.87M 9.39M
Stockholders' Equity Attributable to Parent 339.77M 469.85M -123.13M
Common Stock, Shares, Outstanding 54.24M 53.60M 2.99M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (UPB CIK 0002022626), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

LSF

Laird Superfood, Inc.

TECH

BIO-TECHNE Corp

CNA

CNA FINANCIAL CORP